Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics

BACKGROUND: Persons with schizophrenia are reported to be more likely to die from cardiovascular illness than those in the general population, and are at a greater risk of developing obesity, diabetes type 2, hypertension and dyslipidemias. Antipsychotic drugs used in the treatment of schizophrenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Gautam, Shiv, Meena, Parth Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136014/
https://www.ncbi.nlm.nih.gov/pubmed/21772644
http://dx.doi.org/10.4103/0019-5545.82537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136014/
https://www.ncbi.nlm.nih.gov/pubmed/21772644
http://dx.doi.org/10.4103/0019-5545.82537

Ejemplares similares